Article Information
History
- October 8, 2024.
Article Versions
- Version 1 (March 28, 2024 - 06:41).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Desirée Böck1,#,*,
- Maria Wilhelm1,#,
- Jonas Mumenthaler1,
- Daniel Fabio Carpanese1,
- Peter I. Kulcsár1,
- Simon d‘Aquin1,
- Alessio Cremonesi2,
- Anahita Rassi2,
- Johannes Häberle3,
- Tommaso Patriarchi1,4,* and
- Gerald Schwank1,*
- 1Institute of Pharmacology and Toxicology, University of Zurich, Zürich, Switzerland
- 2Division of Clinical Chemistry and Biochemistry, University Children’s Hospital Zurich, University of Zurich, Zurich, Switzerland
- 3Division of Metabolism and Children’s Research Center, University Children’s Hospital Zurich, Zurich, Switzerland
- 4Neuroscience Center Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland
- ↵*Correspondence: patriarchi{at}pharma.uzh.ch; schwank{at}pharma.uzh.ch; desiree.boeck{at}uzh.ch
↵# These authors contributed equally
Posted October 08, 2024.
Base editing of Ptbp1 in neurons alleviates symptoms in a mouse model of Parkinson’s disease
